Caravel Overview
- Year Founded
-
2022
- Status
-
Private
- Employees
-
9
- Latest Deal Type
-
Grant
- Latest Deal Amount
-
$1.25M
- Investors
-
15
Caravel General Information
Description
Developer of a unified biological engineering platform intended to bridge protein discovery and industrial deployment. The company's platform combines cell-free protein synthesis, bacterial spore display, and machine learning to accelerate directed evolution at scale, enabling synthetic biology researchers and industrial manufacturers across animal health and biochemical production to translate protein breakthroughs into commercially viable applications.
Contact Information
Website
www.caravel.bioCorporate Office
- 4640 South Macadam Avenue
- Portland, OR 97239
- United States
Corporate Office
- 4640 South Macadam Avenue
- Portland, OR 97239
- United States
Caravel Timeline
Caravel Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 15. Grant | 28-Oct-2026 | $1.25M | Completed | Clinical Trials - General | ||
| 14. Accelerator/Incubator | 25-Sep-2026 | Completed | Clinical Trials - General | |||
| 13. Accelerator/Incubator | 02-Feb-2026 | Completed | Clinical Trials - General | |||
| 12. Accelerator/Incubator | 01-Jan-2026 | Completed | Clinical Trials - General | |||
| 11. Grant | 01-Oct-2025 | Completed | Clinical Trials - General | |||
| 10. Accelerator/Incubator | 01-Jun-2025 | Completed | Clinical Trials - General | |||
| 9. Early Stage VC | 01-Jul-2024 | Completed | Clinical Trials - General | |||
| 8. Grant | 20-May-2024 | Completed | Clinical Trials - General | |||
| 7. Seed Round | 14-Dec-2023 | $1.01M | $1.14M | Completed | Clinical Trials - General | |
| 6. Accelerator/Incubator | 18-Oct-2023 | $125K | Completed | Clinical Trials - General |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Caravel Patents
Caravel Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026060257-A1 | Genotype-phenotype self-labeling using orthogonal genetic storage and genetic compilation machinery | Pending | 12-Sep-2024 |
Caravel Signals
Caravel Investors (15)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| BioTools Innovator | Accelerator/Incubator | |||
| Oregon AI Accelerator | Accelerator/Incubator | |||
| MedTech Innovator | Accelerator/Incubator | |||
| Veterinary Health Innovation Engine | Accelerator/Incubator | |||
| Portland Seed Fund | Venture Capital | Minority |
Caravel FAQs
-
When was Caravel founded?
Caravel was founded in 2022.
-
Where is Caravel headquartered?
Caravel is headquartered in Portland, OR.
-
What is the size of Caravel?
Caravel has 9 total employees.
-
What industry is Caravel in?
Caravel’s primary industry is Biotechnology.
-
Is Caravel a private or public company?
Caravel is a Private company.
-
What is Caravel’s current revenue?
The current revenue for Caravel is .
-
How much funding has Caravel raised over time?
Caravel has raised $2.19M.
-
Who are Caravel’s investors?
BioTools Innovator, Oregon AI Accelerator, MedTech Innovator, Veterinary Health Innovation Engine, and Portland Seed Fund are 5 of 15 investors who have invested in Caravel.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process